Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis

Publisher： Karger

E-ISSN： 1662-6575|5|3|530-536

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.3, 2012-09, pp. : 530-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Hodgkin Lymphoma after Treatment with Extended Dosing Temozolomide and Radiotherapy for a Glioblastoma: A Case Report

By  

Case Reports in Oncology, Vol. 6, Iss. 1, 2013-01 ,pp. : 45-49

Karger

Access to resources Recommend Favorite

Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 9, 2015-09 ,pp. : 2427-2436

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bevacizumab‐induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab

By  

CANCER, Vol. 121, Iss. 9, 2015-05 ,pp. : 1456-1462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosis of Geriatric Patients with Severe Dizziness

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 47, Iss. 1, 1999-01 ,pp. : 12-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR-629-3p Level Significantly Predicts Prognosis in Glioblastoma Patients Treated with Temozolomide Chemotherapy

By  

Current Signal Transduction Therapy, Vol. 9, Iss. 1, 2014-04 ,pp. : 9-14

Bentham Science Publishers

Access to resources Recommend Favorite